VOTING AGREEMENTVoting Agreement • July 1st, 2008 • Alkaloida Chemical CO Exclusive Group Ltd. • Pharmaceutical preparations • New York
Contract Type FiledJuly 1st, 2008 Company Industry JurisdictionVOTING AGREEMENT, dated as of May 18, 2007 (this “Agreement”), between SUN PHARMACEUTICAL INDUSTRIES, INC., a Michigan corporation (the “Parent”), and BARRIE LEVITT (the “Shareholder”).
VOTING AGREEMENTVoting Agreement • July 1st, 2008 • Alkaloida Chemical CO Exclusive Group Ltd. • Pharmaceutical preparations
Contract Type FiledJuly 1st, 2008 Company IndustryVOTING AGREEMENT, dated as of May 18, 2007 (this “Agreement”), between ALKALOIDA CHEMICAL COMPANY EXCLUSIVE GROUP LTD. (the “Parent”), and TAL LEVITT (the “Shareholder”).
IRREVOCABLE TRUST AGREEMENTIrrevocable Trust Agreement • June 30th, 2008 • Alkaloida Chemical CO Exclusive Group Ltd. • Pharmaceutical preparations
Contract Type FiledJune 30th, 2008 Company IndustryThis Irrevocable Trust Agreement (the “Agreement”) dated as of June 29, 2008, is entered into by and between Alkaloida Chemical Company Exclusive Group Ltd. (“Depositor”) and Ubank Trust Company Ltd., as trustee (the “Trustee”).
September 20, 2010Alkaloida Chemical CO Exclusive Group Ltd. • September 22nd, 2010 • Pharmaceutical preparations
Company FiledSeptember 22nd, 2010 IndustryThis letter agreement sets forth the actions taken by, and the agreements entered among, the parties hereto pursuant to which they are (a) consummating the transactions contemplated by the Option Letter Agreement dated May 18, 2007 (the “Option Agreement”), among The Taro Development Corporation (“TDC”), Barrie Levitt, Tal Levitt, Daniel Moros, Jacob Levitt and Alkaloida Chemical Company Exclusive Group Ltd. (“Alkaloida”) (together with (i) the Assignment and Assumption Agreement, dated as of June 24, 2008, pursuant to which Sun Pharmaceutical Industries Ltd. (“Sun”) assigned to Alkaloida its rights, and Alkaloida assumed Sun’s obligations, under the Option Agreement and (ii) the Assignment and Assumption Agreement, dated as of August 29, 2008, pursuant to which Alkaloida assigned its rights under and with respect to the TDC Option under Paragraph (1)(a) of the Option Agreement, and all